Vnitr Lek 2023, 69(1):E19-E22 | DOI: 10.36290/vnl.2023.012

Development of chronic venous disease

Jiří Spáčil, Jaroslava Svobodová
Cévní ordinace, Spamed, Praha

Introduction: Chronic venous disease is known to gradually worsen in the course of years. However, little clinical data is available. The patient group and methods: We used the set of our patients with completed clinical examination, duplex sonography and photoplethysmography and selected 160 patients examined at our office after 10 and more years. Females represented 79% in the group. The mean age was 54 years (range 18-82 years). Venous varices in lower limbs in the family were reported by 49% patients. Venous sclerotization had been undergone by 6.3% and venous surgery by 10.6% patients. The mean body mass index was 27. We used CEAP classification. The clinical class C1 included 50 patients, C2 included 81, C3 included 15 and C4 included 14 patients. Regurgitation in superficial veins was found in 43%. The mean venous return time after physical activity was 24.5 s.

Results: The last examination was performed after 13 years on average (range 10-28 years). Deterioration of the clinical condition and progression to a higher class were observed in 36% patients in class C1, in 23.5% patients in C2, in 13% patients in C3 and in 7% patients in C4. We did not demonstrate any statistically significant effect of the followed parameters on the progression of the disease.

Conclusion: The progression rate of the disease in our patient group followed at the vascular office for 10 and more years is lower compared to population studies.

Keywords: chronic venous disease, progression.

Accepted: February 14, 2023; Published: February 17, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Spáčil J, Svobodová J. Development of chronic venous disease. Vnitr Lek. 2023;69(1):E19-22. doi: 10.36290/vnl.2023.012.
Download citation

References

  1. Bobek K, Cajzl L, Čepelák V, et al. Žilní onemocnění a role různých faktorů na jejich vývoj. Čas Lék čes. 1965;104:361-9.
  2. Beebe‑Dimmer JL, Pfeifer JR, Ebgle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol. 2005;15:175-84. Go to original source... Go to PubMed...
  3. Criqui MH, Jamosmos M, Froněk A, et al. Chronic venous disease in an ethnically diverse population. The San Diego population study. Am. J. Epidemiol. 2003; 158:448-456. Go to original source... Go to PubMed...
  4. Rabe E, Guex JJ, Puskas A, et al. Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein consult program. Int Angiol. 2012;31:105-15. Go to PubMed...
  5. Roztočil K, Piťha J, et al. Nemoci končetinových cév. Maxdorf, 2. vydání, 2021, s. 315-345.
  6. De Maeseneer MG, Kakos SK, Aherne T, et al. European society for vascucular Sugery (ESVS) 2022 clinical practice guiedlines on the management of chronic venous disease of the lowerir limbs. Eur J Vasc Endovasc Surg. 2022;63:184-267. Go to original source... Go to PubMed...
  7. Musil D. Co nového přináší aktualizace CEAP klasifikace chronického žilního onemocnění z roku 2020? Vnitr Lek. 2021;67(3):143-1148. Go to original source... Go to PubMed...
  8. Salim S, Machin M, Patterson BO, et al. Global epidemiology of chronic venous disease. Annals of Surgery. 2012;274:971-976. Go to original source... Go to PubMed...
  9. Davies AH. The seriousness of chronic venous disease: A review of real‑world evidence. Adv Ther. 2019;36:S5-S12. Go to original source... Go to PubMed...
  10. Lee AJ, Robertson LA, Boghossian SM, et al. Progression of varicose veins and chronic venous insufficency in the general population in the Edinburgh vein study. J Vasc Surg Venous and Lym, DiS. 2015;3:1826. Go to original source... Go to PubMed...
  11. Labropoulos N, Leon L, Kwon S, et al. Study of the venous reflux progression. J Vasc Surg. 2005;41:291-5. Go to original source... Go to PubMed...
  12. Švejcar J, Přerovský I, Linhart J, Kruml J. Biochemical differences in the composition of primary veins. Am Heart J. 1964;67:572-4. Go to original source... Go to PubMed...
  13. Přerovský I. Patofyziologie žilní cirkulace. In: Fejfar, Z., Přerovský I a spol. Patofyziologie krevního oběhu. Avicenum, Praha, 1980, s. 392-9.
  14. Spáčil J, Svobodová J. Má tělesná výška vliv na závažnost chronického žilního onemocnění? Vnitr Lek. 2015;61(3):202-6. Go to PubMed...
  15. Spáčil J. The importace of ambulatory venous hypertension should be revised. Cardiology and Cardiovascular Research. 2019;3:14-17. Go to original source...
  16. Vincent JR, Jones GT, Hill GB, vanRij AM. Failure of microvenous valve in small superficial veins is a key to the skin ganges of velus insufficiency. J Vasc Surg. 2011; 54:62S-9S. Go to original source... Go to PubMed...
  17. Lugli M, Longhi M, Guerzoni S, Maleti O. Effect of micronized purified flavonoid fraction treatment on microscopic venous valves reflux in C0S and C1S patiens with chronic venous disease. http://europeanvenous forum.org/wp‑content/uploads/2021/06/EVF-2021-Scientific‑Programme‑and‑Book‑of Abstarcts.pdf s. 81.
  18. Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation. 2014;130(4):33346. Go to original source... Go to PubMed...
  19. Shingler SL, Robertson L, Stewart M. Graduated compression stockings for the initial treatment of varicose veins in people without venous ulceration. Cochrane Database Syst. Rev. 2021;16:7(7). Go to original source... Go to PubMed...
  20. Nicolaides A, Kakkos A, Beakgaard N, et al. Managment of chronic venous disorders of the lower limbs. Guidelines according to scientific evidence. Part I. Int Angio. 2018;37:181-254. Go to original source... Go to PubMed...
  21. Nicolaides A, Kakkos S, Baekgaard N, et al. Management of chronic venous disorders of the lower limbs. Guidelines according to scientific evidence. Part II. Int Angiol. 2020;3 (3):175-240. Go to original source... Go to PubMed...
  22. Zimolová P. Proč je důležité léčbu chronického žilního onemocnění nepřerušovat. Cauasa subita. 2022; 25(2):13-15.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.